IP Library Patent Application 17092736
Patent Application
App. No. 17/092,736

SYSTEM AND METHOD FOR PROTEIN CORONA SENSOR ARRAY FOR EARLY DETECTION OF DISEASES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/092,736
Abstract

The present disclosure provides sensor arrays for detecting biomolecules and methods of use. In some embodiments, the sensor arrays are capable of determining a disease state in a subject.

Claims (25)

1 . A method of distinguishing states of a complex biological sample of a subject using a plurality of particles having surfaces with different physicochemical properties, wherein the method comprises:

exposing the complex biological sample to the plurality of particles to permit binding of proteins of the complex biological sample to the plurality of particles, wherein a pattern of binding of proteins amongst the plurality of particles differs based on the physicochemical properties of the surfaces of the particles;

defining a biomolecule fingerprint representative of proteins that bind to the plurality of particles; and

associating the biomolecule fingerprint with a biological state of the subject.

2 . The method of claim 1 , wherein the complex biological sample includes proteins and nucleic acids, and at least one of lipids and polysaccharides.

3 . The method of claim 2 , wherein the complex biological sample is plasma.

4 . The method of claim 1 , wherein the biomolecule fingerprint differs from a second biomolecule fingerprint of a complex biological sample from a second subject not expressing the biological state.

5 . The method of claim 4 , wherein the biological state is a disease state of the subject.

6 . The method of claim 5 , wherein the disease state is at least one of cancer, cardiovascular disease, endocrine disease, inflammatory disease, or a neurological disease.

7 . The method of claim 6 , wherein the disease state is cancer and a cancer type is selected from the group consisting of: lung cancer, pancreas cancer, colon cancer, myeloma, myeloid leukemia, meningioma, glioblastoma, breast cancer, esophageal squamous cell carcinoma, gastric adenocarcinoma, prostate, bladder, ovarian, thyroid, neuroendocrine cancer, and combinations thereof.

8 . The method of claim 7 , wherein the biomolecule fingerprint of the sample is indicative of the cancer type.

9 . The method of claim 6 , wherein the disease state is a neurological disease and the neurological disease is selected from the group consisting of: Alzheimer's disease, brain tumors, epilepsy, Parkinson's disease, ALS, arteriovenous malformation, cerebrovascular disease, brain aneurysms, epilepsy, multiple sclerosis, Peripheral Neuropathy, Post-Herpetic Neuralgia, stroke, frontotemporal dementia, demyelinating disease, multiple sclerosis, Devic's disease, central pontine myelinolysis, progressive multifocal leukoencephalopathy, leukodystrophies, Guillain-Barre syndrome, progressing inflammatory neuropathy, Charcot-Marie-Tooth disease, chronic inflammatory demyelinating polyneuropathy, and anti-MAG peripheral neuropathy.

10 . The method of claim 9 , wherein the disease state is a neurological disease and the neurological disease is Alzheimer's disease.

11 . The method of claim 9 , wherein the biomolecule fingerprint of the sample is indicative of the neurological disease.

12 . The method of claim 1 , wherein the step of defining a biomolecule fingerprint comprises separating at least a subset of the proteins from the plurality of particles.

13 . The method of claim 12 , wherein the step of defining a biomolecule fingerprint further comprises identifying at least one of the proteins of the subset of the proteins separated from the plurality of particles.

14 . The method of claim 13 , wherein identifying at least one of the proteins comprises conducting at least one of gel electrophoresis, liquid chromatography, mass spectrometry, NMR, FTIR, Circular Dichroism, Raman spectrometry, and a combination thereof.

15 . A sensor array comprising a plurality of particles having surfaces with different physicochemical properties, wherein proteins of a complex biological sample bind to the plurality of particles upon exposure of the complex biological sample to the plurality of particles, wherein a pattern of binding of the proteins amongst the plurality of particles depends on the physicochemical property of a surface of the particle.

16 - 27 . (canceled)

28 . A sensor array comprising a plurality of liposomes,

wherein the plurality of liposomes differ in at least one protein-binding property defined by a lipid-based surface of each liposome;

wherein the lipid-based surface of each liposome contacts a subset of proteins of a sample at a lipid-protein interface, thereby binding the subset of proteins to produce a pattern of protein binding;

wherein the pattern of protein binding of a first liposome is different than the pattern of protein binding of a second liposome differing from the first liposome in said at least one protein-binding property.

29 . (canceled)

30 . (canceled)

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2020
From: MAHMOUDI, MORTEZA; FAROKHZAD, OMID C.; CORBO, CLAUDIA
To: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
Reel/Frame 054440/0944 →